share_log

ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate

Benzinga Real-time News ·  Sep 14, 2022 08:08

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment